Avilex Pharma

Investment area
Seed Investments
Region
Europe
Date of investment
February 2013

Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.

Avilex Pharma

Investment area
Seed Investments
Region
Europe
Date of investment
February 2013

Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.

Avilex Pharma

Investment area
Seed Investments
Region
Europe
Date of investment
February 2013

Avilex Pharma develops dimeric peptides that target PSD95 for the treatment of neuropathic pain.